- Trials with a EudraCT protocol (108)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (5)
108 result(s) found for: Peritonitis.
Displaying page 1 of 6.
EudraCT Number: 2008-001367-11 | Sponsor Protocol Number: CIBERehd-ALICANTE-02/08 | Start Date*: 2008-07-31 | |||||||||||
Sponsor Name:UNIDAD HEPATICA. CIBERehd. HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE | |||||||||||||
Full Title: Estudio piloto, en fase IV para evaluar la influencia de la asociación de descontaminación intestinal selectiva (DIS) con norfloxacino a antibioterapia estándar sobre la traslocación bacteriana y ... | |||||||||||||
Medical condition: PERITONITIS BACETERIANA ESPONTÁNEA (SPONTANEOUS BACTERIAL PERITONITIS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016835-36 | Sponsor Protocol Number: PREVIOE-DP | Start Date*: 2011-06-21 | ||||||||||||||||
Sponsor Name:Fundación Investigación Biomédica Hospital Príncipe de Asturias | ||||||||||||||||||
Full Title: ESTUDIO CLÍNICO MULTICÉNTRICO, PROSPECTIVO, ALEATORIZADO, ABIERTO Y CONTROLADO, PARA LA PREVENCIÓN DE LA INFECCIÓN DEL ORIFICIO EXTERNO (IOE) DEL CATÉTER PERITONEAL CON UNA PASTA ANTIBIÓTICA TÓPICA | ||||||||||||||||||
Medical condition: Prevención de la infección del orificio externo (IOE) del catéter peritoneal en pacientes sometidos a diálisis peritoneal por insuficiencia renal crónica. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002708-17 | Sponsor Protocol Number: LOCAL/2016/CR-01 | Start Date*: 2016-11-25 | ||||||||||||||||
Sponsor Name:CHU de NIMES | ||||||||||||||||||
Full Title: Pharmacokinetic study on echinocandins for patients with septic shock following secondary peritonitis | ||||||||||||||||||
Medical condition: septic shock following secondary peritonitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004398-22 | Sponsor Protocol Number: 1 | Start Date*: 2013-07-01 |
Sponsor Name:Afd. A, OUH | ||
Full Title: intraperitoneal microdialysis after server peritonitis | ||
Medical condition: server peritonitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-000391-42 | Sponsor Protocol Number: MD-01 | Start Date*: 2013-01-22 |
Sponsor Name:Martin-Luther-Universität Halle-Wittenberg | ||
Full Title: Investigation on the peritoneal tissue concentrations of antibiotics in surgical patients with peritonitis using microdialysis. Example: linezolide, tigecycline | ||
Medical condition: Peritonitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-005503-26 | Sponsor Protocol Number: CIBERehd-ALICANTE-01/08 | Start Date*: 2009-05-28 |
Sponsor Name:José Such Ronda | ||
Full Title: ESTUDIO MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA DE NORFLOXACINO ORAL ASOCIADO A CEFOTAXIMA EN EL TRATAMIENTO DE LA PERITONITIS BACTERIANA ESPONTÁN... | ||
Medical condition: Peritonitis bacteriana espontánea en pacientes con cirrosis con alto y bajo riesgo de desarrollar complicaciones | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000581-38 | Sponsor Protocol Number: 17/0894 | Start Date*: 2019-07-29 | |||||||||||
Sponsor Name:University College London Comprehensive Clinical Trials Unit | |||||||||||||
Full Title: ASEPTIC: Primary Antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis | |||||||||||||
Medical condition: Spontaneous bacterial peritonitis infection in patients with advanced liver disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006928-18 | Sponsor Protocol Number: 06/Q0603/57 | Start Date*: 2007-04-25 | |||||||||||
Sponsor Name:Barts and The London NHS Trust | |||||||||||||
Full Title: Randomised trial of Prontosan wound gel for prevention of exit site infection in peritoneal dialysis patients | |||||||||||||
Medical condition: Peritoneal dialysis patients and their peritoneal dialysis catheter exit site care. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003527-57 | Sponsor Protocol Number: CACZ885DTR01 | Start Date*: 2016-04-14 | |||||||||||
Sponsor Name:Novartis Pharmaceuticals | |||||||||||||
Full Title: An Open-label, Exploratory Study to Establish the Safety and Efficacy of 3 Months Treatment With Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever | |||||||||||||
Medical condition: Familial Mediterranean Fever | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003522-13 | Sponsor Protocol Number: CACZ885D2204 | Start Date*: 2016-04-14 | |||||||||||
Sponsor Name:Novartis Pharmaceuticals | |||||||||||||
Full Title: A 6 Month Phase 2, Multi-Center, Open-label, Single Arm Study to Evaluate the Safety and Efficacy of Treatment With Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resist... | |||||||||||||
Medical condition: Colchicine Resistant/Intolerant Familial Mediterranean Fever | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004505-13 | Sponsor Protocol Number: TOFFIFE | Start Date*: 2017-11-27 | |||||||||||
Sponsor Name:University Hospital Tuebingen | |||||||||||||
Full Title: Tocilizumab for the Treatment of Familial Mediterranean Fever – A randomized, doubleblind, phase II proof of concept study-TOFFIFE | |||||||||||||
Medical condition: Adult patients with Familial Mediterranean Fever, who have active disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015948-42 | Sponsor Protocol Number: 179 | Start Date*: 2009-10-28 |
Sponsor Name:University of Tartu, Faculty of Medicine | ||
Full Title: Pharmacokinetics of ertapenem in patients with severe sepsis and intraabdominal infection | ||
Medical condition: Severe sepsis caused by intraabdominal infection either peritonitis or pancreatitis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: EE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-003769-41 | Sponsor Protocol Number: ALB1 | Start Date*: 2008-01-31 | |||||||||||
Sponsor Name:Medical University Graz | |||||||||||||
Full Title: Albumin in acute-on-chronic liver failure: More than just volume? A randomized, controlled study | |||||||||||||
Medical condition: Spntaneous bacterial peritonitis | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2011-002093-23 | Sponsor Protocol Number: 1.01 | Start Date*: 2011-09-21 |
Sponsor Name:University of Tartu | ||
Full Title: Bioavailability of oral N-acetylcysteine in different intensive care unit patient groups | ||
Medical condition: Severe neurotrauma, severe pulmonary infections and severe gastrointestinal disease (eg peritonitis, pancreatitis, ileus, major abdominal surgery etc). Need for liquefaction of viscous sputum | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: EE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001913-34 | Sponsor Protocol Number: TP-434-008 | Start Date*: 2013-08-16 | |||||||||||
Sponsor Name:Tetraphase Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared with Ertapenem in Complicated Intra-abdominal Infections | |||||||||||||
Medical condition: Complicated Intra-abdominal Infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) CZ (Completed) EE (Completed) LT (Completed) DE (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002678-77 | Sponsor Protocol Number: 06-108 | Start Date*: 2008-02-09 | |||||||||||
Sponsor Name:CHU Caen | |||||||||||||
Full Title: Analgésie Postopératoire des Appendicectomies en urgence : Effets de l'Instillation Intrapéritonéale et de l’Infiltration Pariétale Locale de Ropivacaine. Etude monocentrique, randomisée en double ... | |||||||||||||
Medical condition: appendectomy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004291-35 | Sponsor Protocol Number: CACZ885N2301 | Start Date*: 2014-05-16 | |||||||||||||||||||||
Sponsor Name:Novartis Farma SpA | |||||||||||||||||||||||
Full Title: A randomized, double-blind, placebo controlled study of canakinumab in patients with Hereditary Periodic Fevers (TRAPS, HIDS, or crFMF), with subsequent randomized withdrawal/ dosing frequency redu... | |||||||||||||||||||||||
Medical condition: Hereditary Periodic Fevers (TRAPS, HIDS, or crFMF) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) ES (Completed) IE (Completed) DE (Completed) BE (Completed) HU (Completed) NL (Completed) GR (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-001788-34 | Sponsor Protocol Number: 15167 | Start Date*: 2018-02-23 | |||||||||||||||||||||
Sponsor Name:University Hospital Aachen, AöR, Dean of the Medical Faculty of the RWTH Aachen for the Managing Board of the University | |||||||||||||||||||||||
Full Title: Prospective, randomized study concerning personalized medicine with Pentaglobin® after interventional infectious source control in peritonitis patients | |||||||||||||||||||||||
Medical condition: Investigation of Pentaglobin® therapy in patients with sepsis and/or septic shock triggered by peritonitis after surgical infectious source control and simultaneous administration of antibiotics. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Trial now transitioned) AT (Trial now transitioned) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000182-19 | Sponsor Protocol Number: CC0401 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Phönix Laboratorium GmbH | |||||||||||||
Full Title: Wirksamkeit und Verträglichkeit von Cholincitrat bei postoperativer Darmatonie nach laparotomischer linksseitiger Hemikolektomie, Sigmaresektion oder Rektumresektion ohne endständiges oder protekti... | |||||||||||||
Medical condition: Postoperative intestinal atony | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001626-26 | Sponsor Protocol Number: INCA | Start Date*: 2015-01-26 | ||||||||||||||||
Sponsor Name:Saarland University | ||||||||||||||||||
Full Title: Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver cirrhosis and ascites (INCA trial) | ||||||||||||||||||
Medical condition: Liver cirrhosis and ascites | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
